Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-08

AUTHORS

K. Yui, Kimihiko Goto, Shigenori Ikemoto, Takeo Ishiguro, Yoshiro Kamada

ABSTRACT

Increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic changes may precipitate stress-related psychiatric disorders. The present study examines the relation between this increased sensitivity and vulnerability to subsequent spontaneous recurrences of methamphetamine (MAP) psychosis (i.e. flashbacks). Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks, of whom ten experienced a single flashback and eight experienced further subsequent flashbacks; in 21 subjects with a history of MAP psychosis who did not experience flashbacks; and 33 controls. A square-root transformation was applied to monoaminergic values, rendering the distribution normal. The subjects with flashbacks had undergone frightening stressful experiences during previous MAP use. The dominant factor triggering flashbacks was a mild fear of other people. During flashbacks, plasma noradrenaline levels markedly increased and 3-methoxytyramine levels, an indicator of dopamine release, were elevated. Among the 18 subjects with flashbacks, the ten with subsequent flashbacks had markedly increased noradrenaline levels during flashbacks, whereas the eight with a single flashback displayed small increases in noradrenaline levels as well as 3-methoxytyramine levels. Thus, a mild fear of other people may have elicited memories of MAP psychosis, related to frightening stressful experiences through increased sensitivity to stress associated with noradrenergic hyperactivity, involving increased dopamine release. Robust noradrenergic hyperreactivity to mild stress may predispose subjects to subsequent flashbacks. More... »

PAGES

267-272

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s002130051058

DOI

http://dx.doi.org/10.1007/s002130051058

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009707339

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10494575


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biogenic Monoamines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Central Nervous System Stimulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methamphetamine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Psychoses, Substance-Induced", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stress, Physiological", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Psychiatry, Jichi Medical School, Tochigi 329-0498, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Department of Psychiatry, Jichi Medical School, Tochigi 329-0498, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yui", 
        "givenName": "K.", 
        "id": "sg:person.0634741564.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634741564.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oyama National College of Technology, Nakakiku 771, Tochigi 323-0806, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.471966.b", 
          "name": [
            "Oyama National College of Technology, Nakakiku 771, Tochigi 323-0806, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goto", 
        "givenName": "Kimihiko", 
        "id": "sg:person.01156104467.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156104467.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Legal Medicine and Human Genetics, Jichi Medical School, Tochigi 329-0498, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Department of Legal Medicine and Human Genetics, Jichi Medical School, Tochigi 329-0498, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ikemoto", 
        "givenName": "Shigenori", 
        "id": "sg:person.015103740511.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015103740511.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Psychiatry, Jichi Medical School, Tochigi 329-0498, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Department of Psychiatry, Jichi Medical School, Tochigi 329-0498, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ishiguro", 
        "givenName": "Takeo", 
        "id": "sg:person.01360655666.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360655666.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Psychiatry, Jichi Medical School, Tochigi 329-0498, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Department of Psychiatry, Jichi Medical School, Tochigi 329-0498, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kamada", 
        "givenName": "Yoshiro", 
        "id": "sg:person.010214652461.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010214652461.64"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1999-08", 
    "datePublishedReg": "1999-08-01", 
    "description": "Abstract\u2002Increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic changes may precipitate stress-related psychiatric disorders. The present study examines the relation between this increased sensitivity and vulnerability to subsequent spontaneous recurrences of methamphetamine (MAP) psychosis (i.e. flashbacks). Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks, of whom ten experienced a single flashback and eight experienced further subsequent flashbacks; in 21 subjects with a history of MAP psychosis who did not experience flashbacks; and 33 controls. A square-root transformation was applied to monoaminergic values, rendering the distribution normal. The subjects with flashbacks had undergone frightening stressful experiences during previous MAP use. The dominant factor triggering flashbacks was a mild fear of other people. During flashbacks, plasma noradrenaline levels markedly increased and 3-methoxytyramine levels, an indicator of dopamine release, were elevated. Among the 18 subjects with flashbacks, the ten with subsequent flashbacks had markedly increased noradrenaline levels during flashbacks, whereas the eight with a single flashback displayed small increases in noradrenaline levels as well as 3-methoxytyramine levels. Thus, a mild fear of other people may have elicited memories of MAP psychosis, related to frightening stressful experiences through increased sensitivity to stress associated with noradrenergic hyperactivity, involving increased dopamine release. Robust noradrenergic hyperreactivity to mild stress may predispose subjects to subsequent flashbacks.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s002130051058", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085440", 
        "issn": [
          "0033-3158", 
          "1432-2072"
        ], 
        "name": "Psychopharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "145"
      }
    ], 
    "keywords": [
      "frightening stressful experiences", 
      "noradrenaline levels", 
      "subsequent flashbacks", 
      "single flashback", 
      "noradrenergic hyperactivity", 
      "spontaneous recurrence", 
      "dopamine release", 
      "methamphetamine psychosis", 
      "MAP psychosis", 
      "stress-related psychiatric disorders", 
      "Plasma monoamine metabolite levels", 
      "subsequent spontaneous recurrences", 
      "mild fear", 
      "monoamine metabolite levels", 
      "previous MAP use", 
      "stressful experiences", 
      "monoaminergic values", 
      "episode recurrence", 
      "dopaminergic changes", 
      "psychiatric disorders", 
      "mild stress", 
      "recurrence", 
      "psychosis", 
      "metabolite levels", 
      "hyperactivity", 
      "subjects", 
      "present study", 
      "small increase", 
      "hyperreactivity", 
      "levels", 
      "release", 
      "sensitivity", 
      "disorders", 
      "fear", 
      "square-root transformation", 
      "flashback", 
      "experience", 
      "people", 
      "factors", 
      "control", 
      "stress", 
      "history", 
      "study", 
      "increase", 
      "changes", 
      "map use", 
      "use", 
      "indicators", 
      "vulnerability", 
      "memory", 
      "values", 
      "relation", 
      "distribution", 
      "dominant factor", 
      "transformation", 
      "experienced further subsequent flashbacks", 
      "further subsequent flashbacks", 
      "Robust noradrenergic hyperreactivity", 
      "noradrenergic hyperreactivity"
    ], 
    "name": "Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis", 
    "pagination": "267-272", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009707339"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s002130051058"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10494575"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s002130051058", 
      "https://app.dimensions.ai/details/publication/pub.1009707339"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_319.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s002130051058"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s002130051058'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s002130051058'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s002130051058'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s002130051058'


 

This table displays all metadata directly associated to this object as RDF triples.

190 TRIPLES      21 PREDICATES      95 URIs      87 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s002130051058 schema:about N1586dcb6500349e9beb9c89ee8d424a2
2 N1ea58f423ced40aea0d61198848266e8
3 N2aa19e5bae22498e9d01003a52b140d4
4 N38bb3876592840869fbfb5de20dd39aa
5 N3bd7e6207e474957886caefa32c82e98
6 N40e4896aa3134a928ee9eaab89c6d707
7 Nb3735106202b42c5ab2cc6430e2d85f0
8 Nd4b413c90de24e6bbe014a73d00a1e6a
9 Nebacb8c809b44c2ea9cbf642a109ffe3
10 anzsrc-for:11
11 anzsrc-for:1109
12 schema:author N35b2f5f4d8d44d4d8c640eb4ec396fc2
13 schema:datePublished 1999-08
14 schema:datePublishedReg 1999-08-01
15 schema:description Abstract Increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic changes may precipitate stress-related psychiatric disorders. The present study examines the relation between this increased sensitivity and vulnerability to subsequent spontaneous recurrences of methamphetamine (MAP) psychosis (i.e. flashbacks). Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks, of whom ten experienced a single flashback and eight experienced further subsequent flashbacks; in 21 subjects with a history of MAP psychosis who did not experience flashbacks; and 33 controls. A square-root transformation was applied to monoaminergic values, rendering the distribution normal. The subjects with flashbacks had undergone frightening stressful experiences during previous MAP use. The dominant factor triggering flashbacks was a mild fear of other people. During flashbacks, plasma noradrenaline levels markedly increased and 3-methoxytyramine levels, an indicator of dopamine release, were elevated. Among the 18 subjects with flashbacks, the ten with subsequent flashbacks had markedly increased noradrenaline levels during flashbacks, whereas the eight with a single flashback displayed small increases in noradrenaline levels as well as 3-methoxytyramine levels. Thus, a mild fear of other people may have elicited memories of MAP psychosis, related to frightening stressful experiences through increased sensitivity to stress associated with noradrenergic hyperactivity, involving increased dopamine release. Robust noradrenergic hyperreactivity to mild stress may predispose subjects to subsequent flashbacks.
16 schema:genre article
17 schema:inLanguage en
18 schema:isAccessibleForFree false
19 schema:isPartOf Nddb81b53a3574764b93f2ea63fbd7e28
20 Nf18c86be6a6e499e8a3ea594addc6a94
21 sg:journal.1085440
22 schema:keywords MAP psychosis
23 Plasma monoamine metabolite levels
24 Robust noradrenergic hyperreactivity
25 changes
26 control
27 disorders
28 distribution
29 dominant factor
30 dopamine release
31 dopaminergic changes
32 episode recurrence
33 experience
34 experienced further subsequent flashbacks
35 factors
36 fear
37 flashback
38 frightening stressful experiences
39 further subsequent flashbacks
40 history
41 hyperactivity
42 hyperreactivity
43 increase
44 indicators
45 levels
46 map use
47 memory
48 metabolite levels
49 methamphetamine psychosis
50 mild fear
51 mild stress
52 monoamine metabolite levels
53 monoaminergic values
54 noradrenaline levels
55 noradrenergic hyperactivity
56 noradrenergic hyperreactivity
57 people
58 present study
59 previous MAP use
60 psychiatric disorders
61 psychosis
62 recurrence
63 relation
64 release
65 sensitivity
66 single flashback
67 small increase
68 spontaneous recurrence
69 square-root transformation
70 stress
71 stress-related psychiatric disorders
72 stressful experiences
73 study
74 subjects
75 subsequent flashbacks
76 subsequent spontaneous recurrences
77 transformation
78 use
79 values
80 vulnerability
81 schema:name Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis
82 schema:pagination 267-272
83 schema:productId N0113372ae1a4412196aaec54239038d7
84 N3d44afc6d44b4e2f8361b4af4dece7d7
85 N799912dc94044e589d9584ce20352a08
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009707339
87 https://doi.org/10.1007/s002130051058
88 schema:sdDatePublished 2021-12-01T19:12
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher Nfd28e137f7be4498a1e36aceddfc13cf
91 schema:url https://doi.org/10.1007/s002130051058
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N0113372ae1a4412196aaec54239038d7 schema:name dimensions_id
96 schema:value pub.1009707339
97 rdf:type schema:PropertyValue
98 N1586dcb6500349e9beb9c89ee8d424a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Biogenic Monoamines
100 rdf:type schema:DefinedTerm
101 N18038f4fc01e4b1db112997290e899bd rdf:first sg:person.01360655666.34
102 rdf:rest N95a58767f02f4100889ee76a33b8e3e1
103 N1ea58f423ced40aea0d61198848266e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Central Nervous System Stimulants
105 rdf:type schema:DefinedTerm
106 N2aa19e5bae22498e9d01003a52b140d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Psychoses, Substance-Induced
108 rdf:type schema:DefinedTerm
109 N35b2f5f4d8d44d4d8c640eb4ec396fc2 rdf:first sg:person.0634741564.44
110 rdf:rest N7784d066b2404f0499b2fa5f3909bb11
111 N38bb3876592840869fbfb5de20dd39aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Female
113 rdf:type schema:DefinedTerm
114 N3bd7e6207e474957886caefa32c82e98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Recurrence
116 rdf:type schema:DefinedTerm
117 N3d44afc6d44b4e2f8361b4af4dece7d7 schema:name pubmed_id
118 schema:value 10494575
119 rdf:type schema:PropertyValue
120 N40e4896aa3134a928ee9eaab89c6d707 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Adult
122 rdf:type schema:DefinedTerm
123 N7784d066b2404f0499b2fa5f3909bb11 rdf:first sg:person.01156104467.13
124 rdf:rest Nb5a0d7ceda824eef8f8d6ae67cb0156c
125 N799912dc94044e589d9584ce20352a08 schema:name doi
126 schema:value 10.1007/s002130051058
127 rdf:type schema:PropertyValue
128 N95a58767f02f4100889ee76a33b8e3e1 rdf:first sg:person.010214652461.64
129 rdf:rest rdf:nil
130 Nb3735106202b42c5ab2cc6430e2d85f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Stress, Physiological
132 rdf:type schema:DefinedTerm
133 Nb5a0d7ceda824eef8f8d6ae67cb0156c rdf:first sg:person.015103740511.08
134 rdf:rest N18038f4fc01e4b1db112997290e899bd
135 Nd4b413c90de24e6bbe014a73d00a1e6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Methamphetamine
137 rdf:type schema:DefinedTerm
138 Nddb81b53a3574764b93f2ea63fbd7e28 schema:issueNumber 3
139 rdf:type schema:PublicationIssue
140 Nebacb8c809b44c2ea9cbf642a109ffe3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Humans
142 rdf:type schema:DefinedTerm
143 Nf18c86be6a6e499e8a3ea594addc6a94 schema:volumeNumber 145
144 rdf:type schema:PublicationVolume
145 Nfd28e137f7be4498a1e36aceddfc13cf schema:name Springer Nature - SN SciGraph project
146 rdf:type schema:Organization
147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
148 schema:name Medical and Health Sciences
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
151 schema:name Neurosciences
152 rdf:type schema:DefinedTerm
153 sg:journal.1085440 schema:issn 0033-3158
154 1432-2072
155 schema:name Psychopharmacology
156 schema:publisher Springer Nature
157 rdf:type schema:Periodical
158 sg:person.010214652461.64 schema:affiliation grid-institutes:grid.410804.9
159 schema:familyName Kamada
160 schema:givenName Yoshiro
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010214652461.64
162 rdf:type schema:Person
163 sg:person.01156104467.13 schema:affiliation grid-institutes:grid.471966.b
164 schema:familyName Goto
165 schema:givenName Kimihiko
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156104467.13
167 rdf:type schema:Person
168 sg:person.01360655666.34 schema:affiliation grid-institutes:grid.410804.9
169 schema:familyName Ishiguro
170 schema:givenName Takeo
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360655666.34
172 rdf:type schema:Person
173 sg:person.015103740511.08 schema:affiliation grid-institutes:grid.410804.9
174 schema:familyName Ikemoto
175 schema:givenName Shigenori
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015103740511.08
177 rdf:type schema:Person
178 sg:person.0634741564.44 schema:affiliation grid-institutes:grid.410804.9
179 schema:familyName Yui
180 schema:givenName K.
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634741564.44
182 rdf:type schema:Person
183 grid-institutes:grid.410804.9 schema:alternateName Department of Legal Medicine and Human Genetics, Jichi Medical School, Tochigi 329-0498, Japan, JP
184 Department of Psychiatry, Jichi Medical School, Tochigi 329-0498, Japan, JP
185 schema:name Department of Legal Medicine and Human Genetics, Jichi Medical School, Tochigi 329-0498, Japan, JP
186 Department of Psychiatry, Jichi Medical School, Tochigi 329-0498, Japan, JP
187 rdf:type schema:Organization
188 grid-institutes:grid.471966.b schema:alternateName Oyama National College of Technology, Nakakiku 771, Tochigi 323-0806, Japan, JP
189 schema:name Oyama National College of Technology, Nakakiku 771, Tochigi 323-0806, Japan, JP
190 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...